Martin Glennie
University of Southampton
H-index: 76
Europe-United Kingdom
Top articles of Martin Glennie
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Combined use of FcγRIIb (CD32B) and CD20 specific antibodies | 2023/4/11 | ||
Reducing affinity as a strategy to boost immunomodulatory antibody agonism | Nature | Xiaojie Yu Christian M Orr HT Claude Chan Sonya James Christine A Penfold | 2023/2/16 |
Combined use of fc gamma riib (cd32b) and cd20 specific antibodies | 2023/11/30 | ||
Immunomodulatory antibodies | 2023/10/10 | ||
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy | Journal of Experimental & Clinical Cancer Research | Khiyam Hussain Rena Liu Rosanna CG Smith Kri TJ Müller Mohammadmersad Ghorbani | 2022/4/7 |
Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody | 2022/9/20 | ||
Conformational regulation in anti-CD40 antibodies | Acta Crystallographica Section A: Foundations and Advances | C Orr H Fisher I Elliott X Yu M Glennie | 2022/8/23 |
Hinge disulfides in human IgG2 CD40 antibodies modulate receptor signaling by regulation of conformation and flexibility | Science immunology | Christian M Orr Hayden Fisher Xiaojie Yu Claude H-T Chan Yunyun Gao | 2022/7/8 |
TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity | Communications Biology | Xiaojie Yu Sonya James James H Felce Blanka Kellermayer David A Johnston | 2021/6/23 |
Modified antibodies containing modified igg2 domains which elicit agonist or antagonistic properties and use thereof | 2021/11/11 | ||
Humane monoklonale antistoffer mod cd20 til anvendelse i behandlingen af multipel sclerose | 2021/7/5 | ||
Impact of Human FcγR Gene Polymorphisms on IgG-Triggered Cytokine Release: Critical Importance of Cell Format Assay | Fc-Mediated Antibody Functions and Fc-Receptor Polymorphism | Khiyam Hussain Chantal E Hargreaves Tania F Rowley Joshua M Sopp Kate V Latham | 2020/7/28 |
Žmogaus monokloniniai antikūnai prieš cd20, skirti naudoti gydant išsėtinę sklerozę | 2020/6/10 | ||
Abstract IA03: Optimizing immunostimulatory antibodies for cancer immunotherapy | Blood Cancer Discovery | Xiaojie Yu Anne White Martin Glennie Ivo Tews Hayden Fisher | 2020/11/1 |
Isotype switching converts anti-CD40 antagonism to agonism to elicit potent antitumor activity | Cancer Cell | Xiaojie Yu HT Claude Chan Hayden Fisher Christine A Penfold Jinny Kim | 2020/6/8 |
Human Monoclonal Antibodies Against CD20 | 2020/10/8 | ||
Domain binding and isotype dictate the activity of anti-human OX40 antibodies | Journal for ImmunoTherapy of Cancer | Jordana Griffiths Khiyam Hussain Hannah L Smith Theodore Sanders Kerry L Cox | 2020 |
LILRB3 (ILT5) is a myeloid checkpoint on myeloid cells that elicits profound immununomodulation | bioRxiv | Muchaala Yeboah Charys Papagregoriou Des C Jones HT Claude Chan Guangan Hu | 2020/6/6 |
LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation | JCI insight | Muchaala Yeboah Charys Papagregoriou Des C Jones HT Claude Chan Guangan Hu | 2020/9/9 |
FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion | Journal for Immunotherapy of Cancer | Robert J Oldham C Ian Mockridge Sonya James Patrick J Duriez HT Claude Chan | 2020 |
